Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
Vilsbøll T, Rosenstock J, Yki-Järvinen H, Cefalu WT, Chen Y, Luo E, Musser B, Andryuk PJ, Ling Y, Kaufman KD, Amatruda JM, Engel SS, Katz L.
Vilsbøll T, et al. Among authors: engel ss.
Diabetes Obes Metab. 2010 Feb;12(2):167-77. doi: 10.1111/j.1463-1326.2009.01173.x.
Diabetes Obes Metab. 2010.
PMID: 20092585
Clinical Trial.